Introduction: Oral biotin supplements taken by patients for various inherited metabolic diseases, demyelinating diseases, or to enhance hair and nail growth, can interfere with certain streptavidin-biotin-based immunoassays, as previously described for certain thyroid function tests. Such interference may cause false-positive (over-estimation) and false-negative (under-estimation) results in competitive and non-competitive immunoassays, respectively. Objective: We investigated the effect of biotin interference in two streptavidin-biotin-based, serologic assays, VITROS Hepatitis B e antigen (HBeAg) and VITROS Hepatitis B e antibodies (anti-Hbe; Ortho-Clinical Diagnostics). Methods: HBeAg and anti-HBe are noncompetitive and competitive immunoassays, respectively, and both were performed with the fully automated VITROS ECi Immunodiagnostic System (Ortho-Clinical Diagnostics). Aliquots of serum were prepared from pooled clinical specimens with three different signal/cutoff (S/CO) ratios, 0.21 (negative), 32.4 (reactive), and 2,220 (reactive) for HBeAg; and cutoff/signal (CO/S) ratios, 0.18 (negative), 2.59 (reactive), and 26.6 (reactive) for anti-HBe. These aliquots were spiked with a 0.9% NaCl solution containing 10,000 ng/mL biotin (Sigma-Aldrich) to achieve final biotin concentrations of 0, 10, 50, 100, 500, and 1,000 ng/mL, and were tested in duplicate for HBeAg and anti-HBe. A difference of >14% between observed and expected S/CO or CO/S ratios was considered significant change, based on manufacturer's precision data for these two assays. Results: HBeAg and anti-HBe immunoassays exhibited significant increases of observed S/CO and CO/S, respectively, ranging from 15% to 99% for HBeAg and from 17% to >1,000% for anti-HBe, at the biotin concentrations evaluated. Significant changes in qualitative interpretative results were observed in HBeAg-reactive and anti-HBe-negative serum samples.
Conclusion:
The VITROS HBeAg and anti-HBe immunoassays are susceptible to biotin interference, leading to a clinically significant change in qualitative interpretive results of originally borderline HBeAg-reactive and originally anti-HBe-negative specimens. Clinical laboratories should recognize that the patient's use of biotin-containing supplements might adversely affect certain laboratory test results. Background: Trichomoniasis is the most prevalent non-viral sexually transmitted infection worldwide. It is caused by the protozoan Trichomonas vaginalis, and the estimated global incidence is over 170 million cases per year, with over 8 million new cases per year in the United States alone. Up to 70% affected are asymptomatic; when symptoms do occur, dysuria, dyspareunia, urethritis, and vaginitis can be observed. Additionally, women are affected at higher rates than men. Despite the relative large overall annual incidence, very few reports have described the characteristics of male patients with T. vaginalis organisms on cytology. Method: We sought to determine the incidence and clinical significance of this finding in the urine cytology of male patients at our medium-sized academic medical center located in a major urban area. We retrospectively reviewed our archived urine cytology slides that reported T. vaginalis organisms spanning a 15-year period. Clinical histories from men with Trichomonas-positive urine were also reviewed and correlated. Slides were reviewed, and the morphologic characteristics of the organisms were recorded. Results: T. vaginalis were detected in nine of 5,094 urine cytology specimens (0.1%). The patients included six women and three men. The age range for men with Trichomonas-positive urine was from 29 to 52 years (mean age, 44 years; median age, 51 years). On cytologic review, T. vaginalis organisms were pear-shaped, oval, or round; they had cyanophilic staining with often evident eosinophilic cytoplasmic granules; there were pale nuclei; and eccentrically located flagella occasionally observed. Acute inflammation was observed in two of three cases. Clinical history was available in three of three men. Lower urinary tract symptoms were reported in three of three men, most commonly hematuria.
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